Is IQVIA Holdings, Inc. overvalued or undervalued?

As of 7 July 2025, the valuation grade for IQVIA Holdings, Inc. moved from fair to expensive, indicating a shift towards overvaluation. The company appears overvalued based on its current metrics, including a P/E ratio of 29, a Price to Book Value of 6.50, and an EV to EBITDA ratio of 15.15. In comparison to peers, Laboratory Corp. of America Holdings has a P/E of 29.20, and Quest Diagnostics, Inc. has a P/E of 27.82, both suggesting that IQVIA's valuation is relatively high.
Additionally, the company's recent stock performance has lagged behind the S&P 500, with a year-to-date return of -3.21% compared to the index's 12.22%, and a one-year return of -21.62% versus 17.14% for the S&P 500. This underperformance reinforces the notion that IQVIA Holdings, Inc. is overvalued in the current market environment.